Home » Topics » Regulatory

Regulatory
RSS

FDA approves Aristada for schizophrenia

Oct. 6, 2015

Maruho's Zebiax approved in Japan for bacterial skin infections

Sep. 30, 2015

Shionogi's Mulpleta approved in Japan for thrombocytopenia

Sep. 29, 2015

GlaxoSmithKline's Zagallo receives approval in Japan

Sep. 29, 2015

Japan first country to approve omarigliptin

Sep. 28, 2015

VivaGel BV approved in E.U. for bacterial vaginosis

Sep. 25, 2015

LFB's IVIg Iqymune approved in U.K. and Denmark

Sep. 22, 2015

FDA approves Vraylar for bipolar disorder and schizophrenia

Sep. 18, 2015

Santhera receives European approval for Raxone in Leber's hereditary optic neuropathy

Sep. 10, 2015

Terumo's autologous skeletal myoblast sheets approved in Japan for heart failure

Sep. 7, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...